Member Info for daringinvestor

I don’t think it’s the fact that Starcom are a minnow. I think it’s due to the product being at very early stages and the fact that they are working on other solutions (my guess) and other pilot projects so do not want to shout out about starcom specifically...

I think a licensing deal or partnership

Not a buy out, especially at this stage of the company's clinical development

AlMHO offcourse

A good summary

According to my notes, they had "a number of new projects under active discussion"

I'm hoping some of those come to fruition

MR is on record stating they (Bosch) see starcom as their partner of choice in developing other bespoke solutions/products, so you're entirely correct in your understanding (IMHO)

and between them they only cover 10% of the market (I believe from an interview that Avi Hartman did some time ago)

So plenty of room for growth as companies pick up on the advantages of container tracking

"Didn't get past the first 5 minutes of the webcast because I noticed it was well over an hour long. Worth watching?"

Are you seriously interested in the company Hawk? Not the best post you've written if you want your posts on the company to be taken seriously surely?

Zwartkops - let's dissect your post a little

"Even when or if a successful stage 3 is announced there is still a million light years to go before any or if a deal is done"
Very misleading statement by Zwartkops. If a successful stage 3 is announced it will not be a million light years before a deal is done. Bear in mind, a lot of the parties have done a lot of due diligence already, so it won't be as if they are starting from scratch so to speak

"then there will be years of manufacturing qualification.. then more than a year of testing.....then when or if it gets to market it will be a long time before any royalties kick in....."
I honestly believe this won't be Futura Medical's problem. The asset will be sold and the potential buyer will look into that.. Again bear in mind, thousands of tubes of this gel were manufactured (by someone), the stability testing has been carried out and is still being carried out.. so again, the buyer will have this data and won't be starting from scratch.

"On the face of it this share looks blue chip all the way and it probably will be one day but your talking 6, 7 years minimum."
I don't think FUM will be waiting that many years for licensing as I believe it'll be sold... Licensing deals have got us no where and based on the info I have, it'll most likely be sold

"I see sub 7p in the not too distance future as share holders begin to see the reality here."
Share prices are a reflection on perceived value in the future..Share holders normally buy in anticipation of future earnings or clinical results.. Not all investors will wait until phase 3 has been completed and a potential deal is signed before buying shares...

Utter crap and misleading info being posted on here...

If the safety can be maintained and benefits to eye sight maintained over a longer term it bodes well for phase 3, as the placebo response for this particular treatment would be very very low

I, like most others purchased this share at a higher price than what it is now. In fact I paid 2.6p and have purchased again in the last week.

I don't post a lot on this forum but thought I'd give my biggest reasons for investing.

For me, when investing in a company, you are first and foremost actually investing in the people running the company..so I ask myself the following very basic questions..

1.Am I assured the management have sufficient exposure to the company to make them care?
2. Am I assured the management are working their a$$es off to make a success of the company?
3. Is the company making progress and has plans in place to grow their revenues and most importantly profit

Nothing has changed for me in the last year (since I invested) and the answers to the above three questions is still a BIG YES.

So I am happy to leave this in the bottom drawer, with the peace of mind that the people running the company are doing their best to make a success of it... We can chat as much as we want, call each other names as much as we want and it won't make a single difference to the fortunes of this company.

Good luck to everyone and I'm backing the management 100 percent.

Spot on Pebsi

when are we expecting them?

"I'd be surprised if this share gets over 2p without a huge increase in the volume of sales."

Well.... that's what the forecast is and it's what we're hoping for!

I hadn't realised the size of this market!

The U.S. market for medical devices generates $180 billion in revenue, making it the largest in the world, according to the 2017 Global Market for Medical Devices report by Kalorama Information.

However, there are still issues that original equipment manufacturers must address as we increasingly rely on portable, battery-powered devices. Variables such as battery chemistry, discharge profiles and the long-term effects of ageing, as well as charge rate, are all problems that continue to perplex many manufacturers.

https://www.ecnmag.com/article/2018/02/choosing-batteries-medical-devices

Hi Rhodi
If phase 3 trial results are statistically significant the European approval can be submitted in 2020 as they do not require a 2nd phase 3

However the FDA would require the 2nd phase 3.

My bet is once the results are announced for the first phase 3, it’ll be sufficiently derisked for the Pharmas/consumer health companies.

Lol
Nice one!

https://www.****************************************interviews.com/interview-ilika-plc-ultra-thin-stereax-batteries-to-deliver-best-in-class-solutions/412767048

Anyone got a link to the Singer note?

Bronxville -I should add some more details.

The side effect profile in a clinical environment is always higher because it's a higher stress environment. Due to the nature of ED, and the symptoms we are trying to treat, we would not measure efficacy in a clinical environment.

We would measure efficacy in sorroundings which are more comfortable for the patients taking part... eg. home/hotel etc...

Phase 3 trials for ED patients are designed for home use. The men will be participating in their own homes. Therefore the females will also be participating in the home too.

This part of the trial does not need to be controlled because they have had the run in period, answered the questionnaire to qualify them into the trial, had the screening etc etc

So not sure what you mean by the home not being a controlled environment.... In summary it does not have to be.

The dose comes in small tubes already containing the amount of gel that needs to be applied. You can't over dose in other words...

Why do women need to participate in a controlled environment?

Phase 3 is meant to be carried out at home.

Not in a controlled clinical environment

Finding women to participate in a controlled environment won’t be so easy.....

Probably the most laughable comment ever !

So a man goes home and is unable to find his wife/ partner? Hahahahaha